ExcaliVir

About:

ExcaliVir is a molecular diagnostics company that offers a microorganisms detecting platform.

Description:

ExcaliVir, a molecular diagnostics company, was formed in 2012 by Dr. Erle Robertson and Dr. James Alwine, researchers from the University of Pennsylvania, Perelman School of Medicine to transform pathogen detection by combining next-generation microarray and sequencing. Their passion for research on the relationship between the microbiome and human cancer has led to the development of a unique technology for the rapid identification of all known infectious agents associated with human disease.

Total Funding Amount:

$734000

Headquarters Location:

Doylestown, Pennsylvania, United States

Founded Date:

2012-01-01

Founders:

Erle Robertson, James Alwine

Number of Employees:

1001-5000

Last Funding Date:

2016-09-21

IPO Status:

Private

Industries: